Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Pediatric PFAPA Syndrome
NCT07476625Not yet recruiting
- Start
- Apr 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
Randomised trial of thalidomide in periodic fever syndrome (2 arms). Primary endpoint: Proportion of Participants Achieving Complete Remission at 6 months. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
periodic fever syndrome
Beyond the preview
Go deeper on NCT07476625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07476625.